Globus Medical GMED Reportable Segment — Foreign currency transaction gain/(loss)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossBeforeTax.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's reportable segment — foreign currency transaction gain/(loss).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Globus Medical's reportable segment — foreign currency transaction gain/(loss)?
- Globus Medical (GMED) reported reportable segment — foreign currency transaction gain/(loss) of -$2.11M in Q1 2026.
- How has Globus Medical's reportable segment — foreign currency transaction gain/(loss) changed year-over-year?
- Globus Medical's reportable segment — foreign currency transaction gain/(loss) decreased by 149.5% year-over-year, from $4.27M to -$2.11M.
- What does reportable segment — foreign currency transaction gain/(loss) mean?
- This captures the impact of fluctuations in exchange rates on transactions denominated in currencies other than the segment's functional currency. It reflects the volatility inherent in international operations and the effectiveness of hedging strategies.